Juliane Ramser
Munich, BY 81675, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
NCALD as a potential predictive biomarker for the efficacy of platinum-based chemotherapy in ovarian cancer.
Journal: Biomarkers in medicine
Published: November 29, 2022
Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 25, 2022
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers.
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers.
Journal: Communications biology
Published: November 15, 2021
Physical activity and Mediterranean diet as potential modulators of osteoprotegerin and soluble RANKL in gBRCA1/2 mutation carriers: results of the lifestyle intervention pilot study LIBRE-1.
Journal: Breast cancer research and treatment
Published: May 31, 2021
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.
Journal: Journal of the National Cancer Institute
Published: February 16, 2021
TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge.
Journal: Archives of gynecology and obstetrics
Published: April 09, 2020
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: November 27, 2019
Criteria of the German Consortium for Hereditary Breast and Ovarian Cancer for the Classification of Germline Sequence Variants in Risk Genes for Hereditary Breast and Ovarian Cancer.
Journal: Geburtshilfe und Frauenheilkunde
Published: November 19, 2019
Last Updated: 09/26/2026